Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: Repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022

被引:0
|
作者
Huiberts, Anne J. [1 ]
van de Hof, Susan [1 ]
Knol, Mirjam J. [1 ]
机构
[1] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands
关键词
D O I
10.1016/j.ijid.2024.107127
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021-May 2023
    Savulescu, Camelia
    Prats-Uribe, Albert
    Brolin, Kim
    Lovric Makaric, Zvjezdana
    Uuskula, Anneli
    Panagiotakopoulos, Georgios
    Bergin, Colm
    Fleming, Catherine
    Agodi, Antonella
    Bonfanti, Paolo
    Murri, Rita
    Zvirbulis, Viesturs
    Zavadska, Dace
    Szuldrzynski, Konstanty
    Machado, Ausenda
    Popescu, Corneliu Petru
    Craiu, Mihai
    Cisneros, Maria
    Latorre-Millan, Miriam
    Petrovic, Goranka
    Lohur, Liis
    Tryfinopoulou, Kyriaki
    Mcgrath, Jonathan
    Ferguson, Lauren
    Barchitta, Martina
    Spolti, Anna
    Donati, Katleen de Gaetano
    Abolina, Ilze
    Gravele, Dagne
    Gaio, Vania
    Florescu, Simin Aysel
    Lazar, Mihaela
    Subirats, Pilar
    Cuesta, Laura Clusa
    Sarajlic, Gordan
    Amerali, Marina
    Sui, Jacklyn
    Kenny, Claire
    Rapisarda, Venerando
    Rossi, Marianna
    Lamonica, Silvia
    Krievins, Dainis
    Barzdina, Elza Anna
    Amaral, Ana Palmira
    Kosa, Alma Gabriela
    Miron, Victor Daniel
    Munoz-Almagro, Carmen
    Milagro, Ana Maria
    Bacci, Sabrina
    Kramarz, Piotr
    VACCINES, 2024, 12 (11)
  • [22] COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study)
    Arashiro, Takeshi
    Arima, Yuzo
    Muraoka, Hirokazu
    Sato, Akihiro
    Oba, Kunihiro
    Uehara, Yuki
    Arioka, Hiroko
    Yanai, Hideki
    Kuramochi, Jin
    Ihara, Genei
    Chubachi, Kumi
    Yanagisawa, Naoki
    Nagura, Yoshito
    Kato, Yasuyuki
    Ueda, Akihiro
    Numata, Akira
    Kato, Hideaki
    Ishii, Koji
    Ooki, Takao
    Oka, Hideaki
    Nishida, Yusuke
    Stucky, Ashley
    Smith, Chris
    Hibberd, Martin
    Ariyoshi, Koya
    Suzuki, Motoi
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E108 - E115
  • [23] Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
    Jostein Starrfelt
    Anders Skyrud Danielsen
    Eirik Alnes Buanes
    Lene Kristine Juvet
    Trude Marie Lyngstad
    Gunnar Øyvind Isaksson Rø
    Lamprini Veneti
    Sara Viksmoen Watle
    Hinta Meijerink
    BMC Medicine, 20
  • [24] Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
    Cromer, Deborah
    Reynaldi, Arnold
    Mitchell, Ainslie
    Schlub, Timothy E.
    Juno, Jennifer A.
    Wheatley, Adam K.
    Kent, Stephen J.
    Khoury, David S.
    Davenport, Miles P.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [25] Sociobehavioural factors associated with SARS-CoV-2 infection and COVID-19 vaccine effectiveness against medically attended, symptomatic SARS-CoV-2 infection in the Philippines: a prospective case-control study (FASCINATE-P study)
    Arashiro, Takeshi
    Berba, Regina Pascua
    Calayo, Joy Potenciano
    Kris, Marie
    Garcia, Reby Marie
    Suzuki, Shuichi
    Dungog, Cecile
    Rivera, Jonathan
    Malijan, Greco Mark
    Agrupis, Kristal An
    Salazar, Mary Jane
    Salazar, Mary Ann
    Shin, Jinho
    Hibberd, Martin
    Ariyoshi, Koya
    Smith, Chris
    WESTERN PACIFIC SURVEILLANCE AND RESPONSE, 2025, 16 (01)
  • [26] An Analysis of SARS-CoV-2 in Wastewater to Evaluate the Effectiveness of Nonpharmaceutical Interventions against COVID-19 in The Netherlands
    Stephens, Natalie
    Been, Frederic
    Savic, Dragan
    ACS ES&T WATER, 2022, : 2158 - 2166
  • [27] Effectiveness of mRNA Vaccine Booster against SARS-CoV-2 Infection and COVID-19 in the Adult Population during the First Three Months of the Omicron Wave in Sicily
    Vella, Giuseppe
    Genovese, Dario
    Belluzzo, Miriam
    Mazzeo, Luca
    Pisciotta, Vincenzo
    Amodio, Emanuele
    HEALTHCARE, 2023, 11 (03)
  • [28] Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 Vaccine AstraZeneca: a prospective multicentre observational cohort study
    Goebel, C.
    Heinze, A.
    Karstedt, S.
    Morscheck, M.
    Tashiro, L.
    Cirkel, A.
    Hamid, Q.
    Halwani, R.
    Temsah, M. H.
    Ziemann, M.
    Goerg, S.
    Muente, T.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 50 - 51
  • [29] Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 Vaccine AstraZeneca: a prospective multicentre observational cohort study
    Goebel, C.
    Heinze, A.
    Karstedt, S.
    Morscheck, M.
    Tashiro, L.
    Cirkel, A.
    Hamid, Q.
    Halwani, R.
    Temsah, M. H.
    Ziemann, M.
    Goerg, S.
    Muente, T.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 33 - 34
  • [30] Integrative proteomics and metabolomics study reveal enhanced immune responses by COVID-19 vaccine booster shot against Omicron SARS-CoV-2 infection
    Wang, Beili
    Yang, Wenjing
    Tong, Yexin
    Sun, Mingjun
    Quan, Sheng
    Zhu, Jing
    Zhang, Qianwen
    Qin, Zhaoyu
    Ni, Yanxia
    Zhao, Ying
    Wang, Kouqiong
    Zhang, Chunyan
    Zhang, Yichi
    Wang, Zhenxin
    Song, Zhenju
    Liu, Huafen
    Fang, Hao
    Kong, Ziqing
    Ding, Chen
    Guo, Wei
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (11)